NCT07341321 SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors Status NOT_YET_RECRUITING Phase N/A
NCT07324824 Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT07317414 β-alanine in the Treatment of Advanced Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT07312162 Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots Status RECRUITING Phase N/A
NCT07310836 A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation Status NOT_YET_RECRUITING Phase N/A
NCT07309419 A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT07290764 Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy Status ENROLLING_BY_INVITATION Phase N/A
NCT07285044 The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas Status RECRUITING Phase PHASE2
NCT07281664 Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase NA
NCT07275073 JMT106 Injection in the Treatment of Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07274774 SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT07272083 New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules Status NOT_YET_RECRUITING Phase N/A
NCT07252661 Study of ACC-1898 in Adult Participants With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT07252323 A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE) Status RECRUITING Phase NA
NCT07246668 A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT07243691 Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT07235410 Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACE Status RECRUITING Phase N/A
NCT07227012 Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. Status RECRUITING Phase PHASE1/PHASE2
NCT07226063 Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07224568 Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1